Editor’s Choice
Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Pharmacy / Pharmacist
Article Date: 28 Oct 2012 – 2:00 PDT
email to a crony printer accessible opinions
<!– rate article
Patient / Public:
Healthcare Prof:
The New England Compounding Center (NECC) trickery has problems progressing a purify rooms, a Food and Drug Administration (FDA) sensitive as it expelled a duplicate of a FDA Form 483 to a NECC.
The FDA says it listed a series of “observations”, including infested products.
FDA inspectors visited NECC for a sum of 7 days from Oct 1st to 26th after a association had removed a steroid medication.
The clean room is an enclosed space that is ostensible to enclose a controlled
Read full article: http://www.google.com/hostednews/afp/article/ALeqM5iZR7_eXHGoaGOSYL6dWRNpHQbI7w?docId=CNG.d5a0551e7ed5dafcddf47b4ced10401b.bd1
Source:
http://www.news.ezonearticle.com/2012/10/28/problems-identified-at-new-england-compounding-center-facility-says-fda/
0 comments:
Post a Comment